title: Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription.
abstract: Inhibition of p53-activated transcription is an integral part of the mechanism by which early region 1B 55K oncoprotein (E1B-55K) from adenovirus type 5 (Ad5) contributes to complete cell transformation in combination with Ad E1A. In addition, more recent data suggest that the mode of action of the Ad protein during transformation may involve additional functions and other protein interactions. In the present study, we performed a comprehensive mutational analysis to assign further transforming functions of Ad5 E1B-55K to distinct domains within the viral polypeptide. Results from these studies show that the functions required for transformation are encoded within several patches of the 55K primary sequence, including several clustered cysteine and histidine residues, some of which match the consensus for zinc fingers. In addition, two amino-acid substitutions (C454S/C456S) created a 55K mutant protein, which had substantially reduced transforming activity. Interestingly, the same mutations neither affected binding to p53 nor inhibition of p53-mediated transactivation. Therefore, an activity necessary for efficient transformation of primary rat cells can be separated from functions required for inhibition of p53-stimulated transcription. Our data indicate that this activity is linked to the ability of the Ad5 protein to bind to components of the Mre11/Rad50/NBS1 DNA double-strand break repair complex, and/or its ability to assemble multiprotein aggregates in the cytoplasm and nucleus of transformed rat cells. These results introduce a new function for Ad5 E1B-55K and suggest that the viral protein contributes to cell transformation through p53 transcription-dependent and -independent pathways.
authors.affiliation: Department of Molecular Virology, Heinrich-Pette-Institute for Experimental Virology and Immunology, Hamburg, Germany.
authors.forename: B
authors.initials: B
authors.lastname: Härtl
authors.forename: T
authors.initials: T
authors.lastname: Zeller
authors.forename: P
authors.initials: P
authors.lastname: Blanchette
authors.forename: E
authors.initials: E
authors.lastname: Kremmer
authors.forename: T
authors.initials: T
authors.lastname: Dobner
mesh_terms: D021581:Active Transport, Cell Nucleus; D017500:Adenovirus E1A Proteins / Q000502:physiology; D017501:Adenovirus E1B Proteins / Q000502:physiology*; D000818:Animals; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D003593:Cytoplasm / Q000378:metabolism; D002479:Inclusion Bodies / Q000378:metabolism; D051381:Rats; D014158:Transcription, Genetic; D016159:Tumor Suppressor Protein p53 / Q000037:antagonists & inhibitors* / Q000502:physiology; D014746:Vimentin / Q000032:analysis
chemical_list: D017500:Adenovirus E1A Proteins; D017501:Adenovirus E1B Proteins; D016159:Tumor Suppressor Protein p53; D014746:Vimentin